Your session is about to expire
← Back to Search
KarMMa-9 Trial Summary
This trial compares the safety, efficacy and tolerance of a new drug to an existing one in people with multiple myeloma who have had a stem cell transplant.
- Multiple Myeloma
KarMMa-9 Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
KarMMa-9 Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
KarMMa-9 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can you appraise the potential risks to participants in Arm A?
"There is existing scientific evidence for the efficacy and safety of Arm A, thus it has been assigned a rating of 3 on our 1-3 scale."
How many healthcare facilities are conducting this research experiment?
"Mayo Clinic in Arizona - Scottsdale, University of California Davis (UC Davis) Comprehensive Cancer Center, Colorado in Arizona - Scottsdale, University of California Davis (UC Davis) Comprehensive Cancer Center, Colorado and Stanford University Medical Center are just a handful of the 107 participating sites for this trial."
Are there any vacancies to join this clinical experiment?
"This research trial, which went live on September 27th 2023 and was last updated on the 22nd of that month, is not currently recruiting patients. Nevertheless, there are 812 clinical trials actively looking for participants across numerous disciplines."
Share this study with friends